Product NDC: | 51079-190 |
Proprietary Name: | Indomethacin |
Non Proprietary Name: | indomethacin |
Active Ingredient(s): | 25 mg/1 & nbsp; indomethacin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-190 |
Labeler Name: | Mylan Institutional Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018858 |
Marketing Category: | NDA |
Start Marketing Date: | 20120803 |
Package NDC: | 51079-190-56 |
Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-190-56) > 30 CAPSULE in 1 BLISTER PACK (51079-190-30) |
NDC Code | 51079-190-56 |
Proprietary Name | Indomethacin |
Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-190-56) > 30 CAPSULE in 1 BLISTER PACK (51079-190-30) |
Product NDC | 51079-190 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | indomethacin |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120803 |
Marketing Category Name | NDA |
Labeler Name | Mylan Institutional Inc. |
Substance Name | INDOMETHACIN |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |